Literature DB >> 6223935

Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases.

S M Rosenthal, M M Grumbach, S L Kaplan.   

Abstract

Four boys with sexual precocity are described in whom pubertal concentrations of plasma testosterone were associated with premature Leydig and germinal cell maturation without activation of the hypothalamic-pituitary gonadotropin unit. Extensive laboratory evaluation localized the source of testosterone secretion to the testes, and testicular biopsy revealed maturation of Leydig cells and spermatogenic elements. These events appear to be nongonadotropin-dependent in view of the absence of a pubertal pattern of pulsatile LH secretion, persistence of a prepubertal LH response to LRF even after long standing sexual precocity, prepubertal basal levels of LH and undetectable hCG, and the absence of biologically active LH-hCG by bioassay. Indirect immunofluorescence studies failed to demonstrate an immunoglobulin in the patients' sera that bound to Leydig cells or seminiferous tubules of normal adult human testes. The potent LRF analog D-Trp6-Pro9-NEt-LRF did not result in suppression of plasma testosterone or Leydig cell function even after 3 months of daily treatment in two patients which provides additional support of pituitary gonadotropin independence and of the lack of a direct effect of the analog on Leydig cell function. Oral medroxyprogesterone acetate treatment in two patients was associated with a striking decrease in both plasma testosterone concentration and height velocity. In the only patient in whom a complete family history could be obtained (three of four patients were adopted), sexual precocity was noted in the maternal grandfather. As this familial syndrome is characterized by a prepubertal hypothalamic-pituitary gonadotropin unit and apparent gonadotropin-independent maturation of Leydig cells and germinal epithelium, possibly due to an intratesticular inborn error, we propose the term "familial testotoxicosis" to describe this group of sexually precocious boys.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6223935     DOI: 10.1210/jcem-57-3-571

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

1.  A new point mutation in the luteinising hormone receptor gene in familial and sporadic male limited precocious puberty: genotype does not always correlate with phenotype.

Authors:  B A Evans; D J Bowen; P J Smith; P E Clayton; J W Gregory
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

Review 2.  Precocious puberty.

Authors:  P Colaco
Journal:  Indian J Pediatr       Date:  1997 Mar-Apr       Impact factor: 1.967

3.  Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.

Authors:  Ellen Werber Leschek; Armando C Flor; Joy C Bryant; Janet V Jones; Kevin M Barnes; Gordon B Cutler
Journal:  J Pediatr       Date:  2017-11       Impact factor: 4.406

4.  Testotoxicosis: gonadotrophin-independent male sexual precocity.

Authors:  A A Aziz; S M Jafri; N U Haque
Journal:  Postgrad Med J       Date:  1992-03       Impact factor: 2.401

5.  Familial testotoxicosis in a Chinese family.

Authors:  Y J Lim; L C Low
Journal:  Eur J Pediatr       Date:  1994-04       Impact factor: 3.183

6.  Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty.

Authors:  L Laue; W Y Chan; A J Hsueh; M Kudo; S Y Hsu; S M Wu; L Blomberg; G B Cutler
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

7.  Precocious puberty and Leydig cell hyperplasia in male mice with a gain of function mutation in the LH receptor gene.

Authors:  Stacey R McGee; Prema Narayan
Journal:  Endocrinology       Date:  2013-07-16       Impact factor: 4.736

Review 8.  GnRH agonists and antagonists. Current clinical status.

Authors:  M Filicori; C Flamigni
Journal:  Drugs       Date:  1988-01       Impact factor: 9.546

9.  Sexual precocity: sex incidence and aetiology.

Authors:  N A Bridges; J A Christopher; P C Hindmarsh; C G Brook
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

Review 10.  Hyperplasia in glands with hormone excess.

Authors:  Stephen J Marx
Journal:  Endocr Relat Cancer       Date:  2015-09-25       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.